Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Prostatic Neoplasms × dexamethasone acetate × Clear all

Phase

Phase NA 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 17 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Recurrence 3 Lymphoma, Non-Hodgkin 2 Smoldering Multiple Myeloma 1 Prostatic Neoplasms 1 Plasmacytoma 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Lymphoma, T-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma 1 Leukemia, Plasma Cell 1 Leukemia, Myeloid, Acute 1 Leukemia, Biphenotypic, Acute 1 Leukemia 1 Immunoglobulin Light-chain Amyloidosis 1 Hypersensitivity 1 Hodgkin Disease 1 Glioma 1 Glioblastoma 1 Castration-Resistant Prostate Carcinoma 1 Burkitt Lymphoma 1 Ann Arbor Stage II Mantle Cell Lymphoma 1 Anemia 1

Interventions

Docetaxel 39 enzalutamide 24 Prednisone 19 Abiraterone Acetate 18 Magnetic Resonance Spectroscopy 17 bicalutamide 13 Radiotherapy 13 pembrolizumab 12 abiraterone 11 Leuprolide 11 Goserelin 11 Cyclophosphamide 11 darolutamide 10 Ipilimumab 10 Specimen Handling 9 Radiosurgery 9 Radiation 9 Biopsy 9 olaparib 8 apalutamide 8 Radiotherapy, Intensity-Modulated 7 Paclitaxel 7 Injections 7 Carboplatin 7 Pluvicto 6 Cisplatin 6 sargramostim 5 radium Ra 223 dichloride 5 Nivolumab 5 Gemcitabine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06136598 2026-02-17

MK-5684-001

Merck Sharp & Dohme LLC

Phase 1 Active not recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡